389819945-NANDA-I-2018-2020-pt-es-pdf

Chee YH, Teoh KH, Sabnis BM, Ballantyne JA, Brenkel IJ. Total hip replacement in
morbidly obese patients with osteoarthritis: results of a prospectively matched study. J
Bone Joint Surg Br. 2010; 92(8):1066– 1071
Chen S, Anderson MV, Cheng WK, Wongworawat MD. Diabetes associated with increased
surgical site infections in spinal arthrodesis. Clin Orthop Relat Res. 2009; 467(7):1670–1673
Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions
correlate with infections in trauma patients in a dose- dependent manner. Am Surg.
2002; 68(7):566–572
Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for pre-term pre- labour rupture of
membranes: prevention of neonatal deaths due to complications of pre-term birth and
infection. Int J Epidemiol. 2010; 39 Suppl 1:i134–i143
Cuellar-Rodríguez J, Sierra-Madero JG. [Infections in solid organ transplant recipients]. Rev
Invest Clin. 2005; 57(2):368–380
Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the
immune response. J Allergy Clin Immunol. 2005; 115(6):1119–1128, quiz 1129
Dorner TE, Schwarz F, Kranz A, Freidl W, Rieder A, Gisinger C. Body mass index and the risk
of infections in institutionalised geriatric patients. Br J Nutr. 2010; 103(12): 1830–1835
Dossett LA, Dageforde LA, Swenson BR, et al. Obesity and site-specific nosocomial infection
risk in the intensive care unit. Surg Infect (Larchmt). 2009; 10(2):137–142
Falagas ME, Kompoti M. (2006). Obesity and infection. Lancet Infectious Diseases, 6,
438–446. Food and Drug Administration (2001). Important drug warning (Remicade).
Retrieved from http://wayback.archive-it.org/
7993/20170112171524/http://www.fda.gov/Safety/MedWatch/SafetyInf
ormation/SafetyAlertsforHumanMedicalProducts/ucm172751.htm
Food and Drug Administration. (2006). FDA approves resumed marketing of